- Home
- PPSI vs PRLD Comparison
PPSI vs PRLD Comparison
Compare PPSI & PRLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PPSI
- PRLD
- Stock Information
- Founded
- PPSI 2008
- PRLD 2016
- Country
- PPSI United States
- PRLD United States
- Employees
- PPSI N/A
- PRLD N/A
- Industry
- PPSI Electrical Products
- PRLD Medicinal Chemicals and Botanical Products
- Sector
- PPSI Industrials
- PRLD Health Care
- Exchange
- PPSI Nasdaq
- PRLD Nasdaq
- Market Cap
- PPSI 46.6M
- PRLD 44.0M
- IPO Year
- PPSI N/A
- PRLD 2020
- Fundamental
- Price
- PPSI $4.53
- PRLD $1.13
- Analyst Decision
- PPSI Strong Buy
- PRLD Strong Buy
- Analyst Count
- PPSI 1
- PRLD 3
- Target Price
- PPSI $12.00
- PRLD $4.00
- AVG Volume (30 Days)
- PPSI 5.2M
- PRLD 223.3K
- Earning Date
- PPSI 11-13-2025
- PRLD 11-05-2025
- Dividend Yield
- PPSI 33.11%
- PRLD N/A
- EPS Growth
- PPSI N/A
- PRLD N/A
- EPS
- PPSI 2.91
- PRLD N/A
- Revenue
- PPSI $31,279,000.00
- PRLD $7,000,000.00
- Revenue This Year
- PPSI $27.32
- PRLD N/A
- Revenue Next Year
- PPSI $16.14
- PRLD N/A
- P/E Ratio
- PPSI $1.53
- PRLD N/A
- Revenue Growth
- PPSI 105.82
- PRLD N/A
- 52 Week Low
- PPSI $2.25
- PRLD $0.61
- 52 Week High
- PPSI $7.00
- PRLD $5.08
- Technical
- Relative Strength Index (RSI)
- PPSI 68.06
- PRLD 51.85
- Support Level
- PPSI $3.65
- PRLD $1.10
- Resistance Level
- PPSI $3.97
- PRLD $1.26
- Average True Range (ATR)
- PPSI 0.27
- PRLD 0.13
- MACD
- PPSI 0.06
- PRLD -0.01
- Stochastic Oscillator
- PPSI 92.56
- PRLD 13.04
About PPSI Pioneer Power Solutions Inc.
Pioneer Power Solutions Inc designs, manufactures, integrates, services, and sells distributed energy resources, on-site and mobile power generation equipment, and a platform of mobile electric vehicle (EV) charging solutions.. Its principal products and services include custom-engineered electrical transformers, switchgear and engine-generator sets and controls, complemented by a national field-service network to maintain and repair power generation assets.
About PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a clinical stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.